Global Cystic Fibrosis Drugs Market Insights and Forecast to 2028

Global Cystic Fibrosis Drugs Market Insights and Forecast to 2028

Table of Contents
1 Study Coverage
1.1 Cystic Fibrosis Drugs Product Introduction
1.2 Market by Type
1.2.1 Global Cystic Fibrosis Drugs Market Size Growth Rate by Type, 2017 VS 2021 VS 2028
1.2.2 Oral Cystic Fibrosis Drugs
1.2.3 Injection Cystic Fibrosis Drugs
1.3 Market by Application
1.3.1 Global Cystic Fibrosis Drugs Market Size Growth Rate by Application, 2017 VS 2021 VS 2028
1.3.2 Hospitals
1.3.3 Clinics
1.3.4 Other
1.4 Study Objectives
1.5 Years Considered
2 Executive Summary
2.1 Global Cystic Fibrosis Drugs Sales Estimates and Forecasts 2017-2028
2.2 Global Cystic Fibrosis Drugs Revenue Estimates and Forecasts 2017-2028
2.3 Global Cystic Fibrosis Drugs Revenue by Region: 2017 VS 2021 VS 2028
2.4 Global Cystic Fibrosis Drugs Sales by Region
2.4.1 Global Cystic Fibrosis Drugs Sales by Region (2017-2022)
2.4.2 Global Sales Cystic Fibrosis Drugs by Region (2023-2028)
2.5 Global Cystic Fibrosis Drugs Revenue by Region
2.5.1 Global Cystic Fibrosis Drugs Revenue by Region (2017-2022)
2.5.2 Global Cystic Fibrosis Drugs Revenue by Region (2023-2028)
2.6 North America
2.7 Europe
2.8 Asia-Pacific
2.9 Latin America
2.10 Middle East & Africa
3 Competition by Manufacturers
3.1 Global Cystic Fibrosis Drugs Sales by Manufacturers
3.1.1 Global Top Cystic Fibrosis Drugs Manufacturers by Sales (2017-2022)
3.1.2 Global Cystic Fibrosis Drugs Sales Market Share by Manufacturers (2017-2022)
3.1.3 Global Top 10 and Top 5 Largest Manufacturers of Cystic Fibrosis Drugs in 2021
3.2 Global Cystic Fibrosis Drugs Revenue by Manufacturers
3.2.1 Global Cystic Fibrosis Drugs Revenue by Manufacturers (2017-2022)
3.2.2 Global Cystic Fibrosis Drugs Revenue Market Share by Manufacturers (2017-2022)
3.2.3 Global Top 10 and Top 5 Companies by Cystic Fibrosis Drugs Revenue in 2021
3.3 Global Cystic Fibrosis Drugs Sales Price by Manufacturers (2017-2022)
3.4 Analysis of Competitive Landscape
3.4.1 Manufacturers Market Concentration Ratio (CR5 and HHI)
3.4.2 Global Cystic Fibrosis Drugs Market Share by Company Type (Tier 1, Tier 2, and Tier 3)
3.4.3 Global Cystic Fibrosis Drugs Manufacturers Geographical Distribution
3.5 Mergers & Acquisitions, Expansion Plans
4 Market Size by Type
4.1 Global Cystic Fibrosis Drugs Sales by Type
4.1.1 Global Cystic Fibrosis Drugs Historical Sales by Type (2017-2022)
4.1.2 Global Cystic Fibrosis Drugs Forecasted Sales by Type (2023-2028)
4.1.3 Global Cystic Fibrosis Drugs Sales Market Share by Type (2017-2028)
4.2 Global Cystic Fibrosis Drugs Revenue by Type
4.2.1 Global Cystic Fibrosis Drugs Historical Revenue by Type (2017-2022)
4.2.2 Global Cystic Fibrosis Drugs Forecasted Revenue by Type (2023-2028)
4.2.3 Global Cystic Fibrosis Drugs Revenue Market Share by Type (2017-2028)
4.3 Global Cystic Fibrosis Drugs Price by Type
4.3.1 Global Cystic Fibrosis Drugs Price by Type (2017-2022)
4.3.2 Global Cystic Fibrosis Drugs Price Forecast by Type (2023-2028)
5 Market Size by Application
5.1 Global Cystic Fibrosis Drugs Sales by Application
5.1.1 Global Cystic Fibrosis Drugs Historical Sales by Application (2017-2022)
5.1.2 Global Cystic Fibrosis Drugs Forecasted Sales by Application (2023-2028)
5.1.3 Global Cystic Fibrosis Drugs Sales Market Share by Application (2017-2028)
5.2 Global Cystic Fibrosis Drugs Revenue by Application
5.2.1 Global Cystic Fibrosis Drugs Historical Revenue by Application (2017-2022)
5.2.2 Global Cystic Fibrosis Drugs Forecasted Revenue by Application (2023-2028)
5.2.3 Global Cystic Fibrosis Drugs Revenue Market Share by Application (2017-2028)
5.3 Global Cystic Fibrosis Drugs Price by Application
5.3.1 Global Cystic Fibrosis Drugs Price by Application (2017-2022)
5.3.2 Global Cystic Fibrosis Drugs Price Forecast by Application (2023-2028)
6 North America
6.1 North America Cystic Fibrosis Drugs Market Size by Type
6.1.1 North America Cystic Fibrosis Drugs Sales by Type (2017-2028)
6.1.2 North America Cystic Fibrosis Drugs Revenue by Type (2017-2028)
6.2 North America Cystic Fibrosis Drugs Market Size by Application
6.2.1 North America Cystic Fibrosis Drugs Sales by Application (2017-2028)
6.2.2 North America Cystic Fibrosis Drugs Revenue by Application (2017-2028)
6.3 North America Cystic Fibrosis Drugs Market Size by Country
6.3.1 North America Cystic Fibrosis Drugs Sales by Country (2017-2028)
6.3.2 North America Cystic Fibrosis Drugs Revenue by Country (2017-2028)
6.3.3 U.S.
6.3.4 Canada
7 Europe
7.1 Europe Cystic Fibrosis Drugs Market Size by Type
7.1.1 Europe Cystic Fibrosis Drugs Sales by Type (2017-2028)
7.1.2 Europe Cystic Fibrosis Drugs Revenue by Type (2017-2028)
7.2 Europe Cystic Fibrosis Drugs Market Size by Application
7.2.1 Europe Cystic Fibrosis Drugs Sales by Application (2017-2028)
7.2.2 Europe Cystic Fibrosis Drugs Revenue by Application (2017-2028)
7.3 Europe Cystic Fibrosis Drugs Market Size by Country
7.3.1 Europe Cystic Fibrosis Drugs Sales by Country (2017-2028)
7.3.2 Europe Cystic Fibrosis Drugs Revenue by Country (2017-2028)
7.3.3 Germany
7.3.4 France
7.3.5 U.K.
7.3.6 Italy
7.3.7 Russia
8 Asia Pacific
8.1 Asia Pacific Cystic Fibrosis Drugs Market Size by Type
8.1.1 Asia Pacific Cystic Fibrosis Drugs Sales by Type (2017-2028)
8.1.2 Asia Pacific Cystic Fibrosis Drugs Revenue by Type (2017-2028)
8.2 Asia Pacific Cystic Fibrosis Drugs Market Size by Application
8.2.1 Asia Pacific Cystic Fibrosis Drugs Sales by Application (2017-2028)
8.2.2 Asia Pacific Cystic Fibrosis Drugs Revenue by Application (2017-2028)
8.3 Asia Pacific Cystic Fibrosis Drugs Market Size by Region
8.3.1 Asia Pacific Cystic Fibrosis Drugs Sales by Region (2017-2028)
8.3.2 Asia Pacific Cystic Fibrosis Drugs Revenue by Region (2017-2028)
8.3.3 China
8.3.4 Japan
8.3.5 South Korea
8.3.6 India
8.3.7 Australia
8.3.8 China Taiwan
8.3.9 Indonesia
8.3.10 Thailand
8.3.11 Malaysia
9 Latin America
9.1 Latin America Cystic Fibrosis Drugs Market Size by Type
9.1.1 Latin America Cystic Fibrosis Drugs Sales by Type (2017-2028)
9.1.2 Latin America Cystic Fibrosis Drugs Revenue by Type (2017-2028)
9.2 Latin America Cystic Fibrosis Drugs Market Size by Application
9.2.1 Latin America Cystic Fibrosis Drugs Sales by Application (2017-2028)
9.2.2 Latin America Cystic Fibrosis Drugs Revenue by Application (2017-2028)
9.3 Latin America Cystic Fibrosis Drugs Market Size by Country
9.3.1 Latin America Cystic Fibrosis Drugs Sales by Country (2017-2028)
9.3.2 Latin America Cystic Fibrosis Drugs Revenue by Country (2017-2028)
9.3.3 Mexico
9.3.4 Brazil
9.3.5 Argentina
10 Middle East and Africa
10.1 Middle East and Africa Cystic Fibrosis Drugs Market Size by Type
10.1.1 Middle East and Africa Cystic Fibrosis Drugs Sales by Type (2017-2028)
10.1.2 Middle East and Africa Cystic Fibrosis Drugs Revenue by Type (2017-2028)
10.2 Middle East and Africa Cystic Fibrosis Drugs Market Size by Application
10.2.1 Middle East and Africa Cystic Fibrosis Drugs Sales by Application (2017-2028)
10.2.2 Middle East and Africa Cystic Fibrosis Drugs Revenue by Application (2017-2028)
10.3 Middle East and Africa Cystic Fibrosis Drugs Market Size by Country
10.3.1 Middle East and Africa Cystic Fibrosis Drugs Sales by Country (2017-2028)
10.3.2 Middle East and Africa Cystic Fibrosis Drugs Revenue by Country (2017-2028)
10.3.3 Turkey
10.3.4 Saudi Arabia
11 Company Profiles
11.1 Actavis
11.1.1 Actavis Corporation Information
11.1.2 Actavis Overview
11.1.3 Actavis Cystic Fibrosis Drugs Sales, Price, Revenue and Gross Margin (2017-2022)
11.1.4 Actavis Cystic Fibrosis Drugs Product Model Numbers, Pictures, Descriptions and Specifications
11.1.5 Actavis Recent Developments
11.2 F. Hoffmann-La Roche
11.2.1 F. Hoffmann-La Roche Corporation Information
11.2.2 F. Hoffmann-La Roche Overview
11.2.3 F. Hoffmann-La Roche Cystic Fibrosis Drugs Sales, Price, Revenue and Gross Margin (2017-2022)
11.2.4 F. Hoffmann-La Roche Cystic Fibrosis Drugs Product Model Numbers, Pictures, Descriptions and Specifications
11.2.5 F. Hoffmann-La Roche Recent Developments
11.3 Gilead Sciences
11.3.1 Gilead Sciences Corporation Information
11.3.2 Gilead Sciences Overview
11.3.3 Gilead Sciences Cystic Fibrosis Drugs Sales, Price, Revenue and Gross Margin (2017-2022)
11.3.4 Gilead Sciences Cystic Fibrosis Drugs Product Model Numbers, Pictures, Descriptions and Specifications
11.3.5 Gilead Sciences Recent Developments
11.4 Novartis
11.4.1 Novartis Corporation Information
11.4.2 Novartis Overview
11.4.3 Novartis Cystic Fibrosis Drugs Sales, Price, Revenue and Gross Margin (2017-2022)
11.4.4 Novartis Cystic Fibrosis Drugs Product Model Numbers, Pictures, Descriptions and Specifications
11.4.5 Novartis Recent Developments
11.5 Vertex Pharmaceuticals
11.5.1 Vertex Pharmaceuticals Corporation Information
11.5.2 Vertex Pharmaceuticals Overview
11.5.3 Vertex Pharmaceuticals Cystic Fibrosis Drugs Sales, Price, Revenue and Gross Margin (2017-2022)
11.5.4 Vertex Pharmaceuticals Cystic Fibrosis Drugs Product Model Numbers, Pictures, Descriptions and Specifications
11.5.5 Vertex Pharmaceuticals Recent Developments
11.6 Abbott
11.6.1 Abbott Corporation Information
11.6.2 Abbott Overview
11.6.3 Abbott Cystic Fibrosis Drugs Sales, Price, Revenue and Gross Margin (2017-2022)
11.6.4 Abbott Cystic Fibrosis Drugs Product Model Numbers, Pictures, Descriptions and Specifications
11.6.5 Abbott Recent Developments
11.7 Anthera Pharmaceuticals
11.7.1 Anthera Pharmaceuticals Corporation Information
11.7.2 Anthera Pharmaceuticals Overview
11.7.3 Anthera Pharmaceuticals Cystic Fibrosis Drugs Sales, Price, Revenue and Gross Margin (2017-2022)
11.7.4 Anthera Pharmaceuticals Cystic Fibrosis Drugs Product Model Numbers, Pictures, Descriptions and Specifications
11.7.5 Anthera Pharmaceuticals Recent Developments
11.8 Arcturus Therapeutics
11.8.1 Arcturus Therapeutics Corporation Information
11.8.2 Arcturus Therapeutics Overview
11.8.3 Arcturus Therapeutics Cystic Fibrosis Drugs Sales, Price, Revenue and Gross Margin (2017-2022)
11.8.4 Arcturus Therapeutics Cystic Fibrosis Drugs Product Model Numbers, Pictures, Descriptions and Specifications
11.8.5 Arcturus Therapeutics Recent Developments
11.9 Boehringer Ingelheim
11.9.1 Boehringer Ingelheim Corporation Information
11.9.2 Boehringer Ingelheim Overview
11.9.3 Boehringer Ingelheim Cystic Fibrosis Drugs Sales, Price, Revenue and Gross Margin (2017-2022)
11.9.4 Boehringer Ingelheim Cystic Fibrosis Drugs Product Model Numbers, Pictures, Descriptions and Specifications
11.9.5 Boehringer Ingelheim Recent Developments
11.10 Chiesi Farmaceutici
11.10.1 Chiesi Farmaceutici Corporation Information
11.10.2 Chiesi Farmaceutici Overview
11.10.3 Chiesi Farmaceutici Cystic Fibrosis Drugs Sales, Price, Revenue and Gross Margin (2017-2022)
11.10.4 Chiesi Farmaceutici Cystic Fibrosis Drugs Product Model Numbers, Pictures, Descriptions and Specifications
11.10.5 Chiesi Farmaceutici Recent Developments
11.11 Corbus Pharmaceuticals
11.11.1 Corbus Pharmaceuticals Corporation Information
11.11.2 Corbus Pharmaceuticals Overview
11.11.3 Corbus Pharmaceuticals Cystic Fibrosis Drugs Sales, Price, Revenue and Gross Margin (2017-2022)
11.11.4 Corbus Pharmaceuticals Cystic Fibrosis Drugs Product Model Numbers, Pictures, Descriptions and Specifications
11.11.5 Corbus Pharmaceuticals Recent Developments
11.12 Genzyme
11.12.1 Genzyme Corporation Information
11.12.2 Genzyme Overview
11.12.3 Genzyme Cystic Fibrosis Drugs Sales, Price, Revenue and Gross Margin (2017-2022)
11.12.4 Genzyme Cystic Fibrosis Drugs Product Model Numbers, Pictures, Descriptions and Specifications
11.12.5 Genzyme Recent Developments
11.13 Insmed
11.13.1 Insmed Corporation Information
11.13.2 Insmed Overview
11.13.3 Insmed Cystic Fibrosis Drugs Sales, Price, Revenue and Gross Margin (2017-2022)
11.13.4 Insmed Cystic Fibrosis Drugs Product Model Numbers, Pictures, Descriptions and Specifications
11.13.5 Insmed Recent Developments
11.14 Johnson & Johnson
11.14.1 Johnson & Johnson Corporation Information
11.14.2 Johnson & Johnson Overview
11.14.3 Johnson & Johnson Cystic Fibrosis Drugs Sales, Price, Revenue and Gross Margin (2017-2022)
11.14.4 Johnson & Johnson Cystic Fibrosis Drugs Product Model Numbers, Pictures, Descriptions and Specifications
11.14.5 Johnson & Johnson Recent Developments
11.15 Merck Sharp & Dohme
11.15.1 Merck Sharp & Dohme Corporation Information
11.15.2 Merck Sharp & Dohme Overview
11.15.3 Merck Sharp & Dohme Cystic Fibrosis Drugs Sales, Price, Revenue and Gross Margin (2017-2022)
11.15.4 Merck Sharp & Dohme Cystic Fibrosis Drugs Product Model Numbers, Pictures, Descriptions and Specifications
11.15.5 Merck Sharp & Dohme Recent Developments
11.16 Neovii Biotech
11.16.1 Neovii Biotech Corporation Information
11.16.2 Neovii Biotech Overview
11.16.3 Neovii Biotech Cystic Fibrosis Drugs Sales, Price, Revenue and Gross Margin (2017-2022)
11.16.4 Neovii Biotech Cystic Fibrosis Drugs Product Model Numbers, Pictures, Descriptions and Specifications
11.16.5 Neovii Biotech Recent Developments
11.17 Novo Nordisk
11.17.1 Novo Nordisk Corporation Information
11.17.2 Novo Nordisk Overview
11.17.3 Novo Nordisk Cystic Fibrosis Drugs Sales, Price, Revenue and Gross Margin (2017-2022)
11.17.4 Novo Nordisk Cystic Fibrosis Drugs Product Model Numbers, Pictures, Descriptions and Specifications
11.17.5 Novo Nordisk Recent Developments
11.18 PharmaSwiss
11.18.1 PharmaSwiss Corporation Information
11.18.2 PharmaSwiss Overview
11.18.3 PharmaSwiss Cystic Fibrosis Drugs Sales, Price, Revenue and Gross Margin (2017-2022)
11.18.4 PharmaSwiss Cystic Fibrosis Drugs Product Model Numbers, Pictures, Descriptions and Specifications
11.18.5 PharmaSwiss Recent Developments
11.19 Pharmaxis
11.19.1 Pharmaxis Corporation Information
11.19.2 Pharmaxis Overview
11.19.3 Pharmaxis Cystic Fibrosis Drugs Sales, Price, Revenue and Gross Margin (2017-2022)
11.19.4 Pharmaxis Cystic Fibrosis Drugs Product Model Numbers, Pictures, Descriptions and Specifications
11.19.5 Pharmaxis Recent Developments
11.20 Proteostasis Therapeutics
11.20.1 Proteostasis Therapeutics Corporation Information
11.20.2 Proteostasis Therapeutics Overview
11.20.3 Proteostasis Therapeutics Cystic Fibrosis Drugs Sales, Price, Revenue and Gross Margin (2017-2022)
11.20.4 Proteostasis Therapeutics Cystic Fibrosis Drugs Product Model Numbers, Pictures, Descriptions and Specifications
11.20.5 Proteostasis Therapeutics Recent Developments
11.21 PTC Therapeutics
11.21.1 PTC Therapeutics Corporation Information
11.21.2 PTC Therapeutics Overview
11.21.3 PTC Therapeutics Cystic Fibrosis Drugs Sales, Price, Revenue and Gross Margin (2017-2022)
11.21.4 PTC Therapeutics Cystic Fibrosis Drugs Product Model Numbers, Pictures, Descriptions and Specifications
11.21.5 PTC Therapeutics Recent Developments
11.22 United Medical
11.22.1 United Medical Corporation Information
11.22.2 United Medical Overview
11.22.3 United Medical Cystic Fibrosis Drugs Sales, Price, Revenue and Gross Margin (2017-2022)
11.22.4 United Medical Cystic Fibrosis Drugs Product Model Numbers, Pictures, Descriptions and Specifications
11.22.5 United Medical Recent Developments
11.23 Venus Remedies
11.23.1 Venus Remedies Corporation Information
11.23.2 Venus Remedies Overview
11.23.3 Venus Remedies Cystic Fibrosis Drugs Sales, Price, Revenue and Gross Margin (2017-2022)
11.23.4 Venus Remedies Cystic Fibrosis Drugs Product Model Numbers, Pictures, Descriptions and Specifications
11.23.5 Venus Remedies Recent Developments
12 Industry Chain and Sales Channels Analysis
12.1 Cystic Fibrosis Drugs Industry Chain Analysis
12.2 Cystic Fibrosis Drugs Key Raw Materials
12.2.1 Key Raw Materials
12.2.2 Raw Materials Key Suppliers
12.3 Cystic Fibrosis Drugs Production Mode & Process
12.4 Cystic Fibrosis Drugs Sales and Marketing
12.4.1 Cystic Fibrosis Drugs Sales Channels
12.4.2 Cystic Fibrosis Drugs Distributors
12.5 Cystic Fibrosis Drugs Customers
13 Market Drivers, Opportunities, Challenges and Risks Factors Analysis
13.1 Cystic Fibrosis Drugs Industry Trends
13.2 Cystic Fibrosis Drugs Market Drivers
13.3 Cystic Fibrosis Drugs Market Challenges
13.4 Cystic Fibrosis Drugs Market Restraints
14 Key Findings in The Global Cystic Fibrosis Drugs Study
15 Appendix
15.1 Research Methodology
15.1.1 Methodology/Research Approach
15.1.2 Data Source
15.2 Author Details
15.3 Disclaimer
List of Tables
Table 1. Global Cystic Fibrosis Drugs Market Size Growth Rate by Type, 2017 VS 2021 VS 2028 (US$ Million)
Table 2. Major Manufacturers of Oral Cystic Fibrosis Drugs
Table 3. Major Manufacturers of Injection Cystic Fibrosis Drugs
Table 4. Global Cystic Fibrosis Drugs Market Size Growth Rate by Application, 2017 VS 2021 VS 2028 (US$ Million)
Table 5. Global Cystic Fibrosis Drugs Revenue by Region: 2017 VS 2021 VS 2028 (US$ Million)
Table 6. Global Cystic Fibrosis Drugs Sales by Region (2017-2022) & (K Pcs)
Table 7. Global Cystic Fibrosis Drugs Sales Market Share by Region (2017-2022)
Table 8. Global Cystic Fibrosis Drugs Sales by Region (2023-2028) & (K Pcs)
Table 9. Global Cystic Fibrosis Drugs Sales Market Share by Region (2023-2028)
Table 10. Global Cystic Fibrosis Drugs Revenue by Region (2017-2022) & (US$ Million)
Table 11. Global Cystic Fibrosis Drugs Revenue Market Share by Region (2017-2022)
Table 12. Global Cystic Fibrosis Drugs Revenue by Region (2023-2028) & (US$ Million)
Table 13. Global Cystic Fibrosis Drugs Revenue Market Share by Region (2023-2028)
Table 14. Global Cystic Fibrosis Drugs Sales by Manufacturers (2017-2022) & (K Pcs)
Table 15. Global Cystic Fibrosis Drugs Sales Share by Manufacturers (2017-2022)
Table 16. Global Cystic Fibrosis Drugs Revenue by Manufacturers (2017-2022) & (US$ Million)
Table 17. Global Cystic Fibrosis Drugs Revenue Share by Manufacturers (2017-2022)
Table 18. Cystic Fibrosis Drugs Price by Manufacturers (2017-2022) &(USD/Pcs)
Table 19. Global Cystic Fibrosis Drugs Manufacturers Market Concentration Ratio (CR5 and HHI)
Table 20. Global Cystic Fibrosis Drugs by Company Type (Tier 1, Tier 2, and Tier 3) & (based on the Revenue in Cystic Fibrosis Drugs as of 2021)
Table 21. Cystic Fibrosis Drugs Manufacturing Base Distribution and Headquarters
Table 22. Manufacturers Cystic Fibrosis Drugs Product Offered
Table 23. Date of Manufacturers Enter into Cystic Fibrosis Drugs Market
Table 24. Mergers & Acquisitions, Expansion Plans
Table 25. Global Cystic Fibrosis Drugs Sales by Type (2017-2022) & (K Pcs)
Table 26. Global Cystic Fibrosis Drugs Sales by Type (2023-2028) & (K Pcs)
Table 27. Global Cystic Fibrosis Drugs Sales Share by Type (2017-2022)
Table 28. Global Cystic Fibrosis Drugs Sales Share by Type (2023-2028)
Table 29. Global Cystic Fibrosis Drugs Revenue by Type (2017-2022) & (US$ Million)
Table 30. Global Cystic Fibrosis Drugs Revenue by Type (2023-2028) & (US$ Million)
Table 31. Global Cystic Fibrosis Drugs Revenue Share by Type (2017-2022)
Table 32. Global Cystic Fibrosis Drugs Revenue Share by Type (2023-2028)
Table 33. Cystic Fibrosis Drugs Price by Type (2017-2022) & (USD/Pcs)
Table 34. Global Cystic Fibrosis Drugs Price Forecast by Type (2023-2028) & (USD/Pcs)
Table 35. Global Cystic Fibrosis Drugs Sales by Application (2017-2022) & (K Pcs)
Table 36. Global Cystic Fibrosis Drugs Sales by Application (2023-2028) & (K Pcs)
Table 37. Global Cystic Fibrosis Drugs Sales Share by Application (2017-2022)
Table 38. Global Cystic Fibrosis Drugs Sales Share by Application (2023-2028)
Table 39. Global Cystic Fibrosis Drugs Revenue by Application (2017-2022) & (US$ Million)
Table 40. Global Cystic Fibrosis Drugs Revenue by Application (2023-2028) & (US$ Million)
Table 41. Global Cystic Fibrosis Drugs Revenue Share by Application (2017-2022)
Table 42. Global Cystic Fibrosis Drugs Revenue Share by Application (2023-2028)
Table 43. Cystic Fibrosis Drugs Price by Application (2017-2022) & (USD/Pcs)
Table 44. Global Cystic Fibrosis Drugs Price Forecast by Application (2023-2028) & (USD/Pcs)
Table 45. North America Cystic Fibrosis Drugs Sales by Type (2017-2022) & (K Pcs)
Table 46. North America Cystic Fibrosis Drugs Sales by Type (2023-2028) & (K Pcs)
Table 47. North America Cystic Fibrosis Drugs Revenue by Type (2017-2022) & (US$ Million)
Table 48. North America Cystic Fibrosis Drugs Revenue by Type (2023-2028) & (US$ Million)
Table 49. North America Cystic Fibrosis Drugs Sales by Application (2017-2022) & (K Pcs)
Table 50. North America Cystic Fibrosis Drugs Sales by Application (2023-2028) & (K Pcs)
Table 51. North America Cystic Fibrosis Drugs Revenue by Application (2017-2022) & (US$ Million)
Table 52. North America Cystic Fibrosis Drugs Revenue by Application (2023-2028) & (US$ Million)
Table 53. North America Cystic Fibrosis Drugs Sales by Country (2017-2022) & (K Pcs)
Table 54. North America Cystic Fibrosis Drugs Sales by Country (2023-2028) & (K Pcs)
Table 55. North America Cystic Fibrosis Drugs Revenue by Country (2017-2022) & (US$ Million)
Table 56. North America Cystic Fibrosis Drugs Revenue by Country (2023-2028) & (US$ Million)
Table 57. Europe Cystic Fibrosis Drugs Sales by Type (2017-2022) & (K Pcs)
Table 58. Europe Cystic Fibrosis Drugs Sales by Type (2023-2028) & (K Pcs)
Table 59. Europe Cystic Fibrosis Drugs Revenue by Type (2017-2022) & (US$ Million)
Table 60. Europe Cystic Fibrosis Drugs Revenue by Type (2023-2028) & (US$ Million)
Table 61. Europe Cystic Fibrosis Drugs Sales by Application (2017-2022) & (K Pcs)
Table 62. Europe Cystic Fibrosis Drugs Sales by Application (2023-2028) & (K Pcs)
Table 63. Europe Cystic Fibrosis Drugs Revenue by Application (2017-2022) & (US$ Million)
Table 64. Europe Cystic Fibrosis Drugs Revenue by Application (2023-2028) & (US$ Million)
Table 65. Europe Cystic Fibrosis Drugs Sales by Country (2017-2022) & (K Pcs)
Table 66. Europe Cystic Fibrosis Drugs Sales by Country (2023-2028) & (K Pcs)
Table 67. Europe Cystic Fibrosis Drugs Revenue by Country (2017-2022) & (US$ Million)
Table 68. Europe Cystic Fibrosis Drugs Revenue by Country (2023-2028) & (US$ Million)
Table 69. Asia Pacific Cystic Fibrosis Drugs Sales by Type (2017-2022) & (K Pcs)
Table 70. Asia Pacific Cystic Fibrosis Drugs Sales by Type (2023-2028) & (K Pcs)
Table 71. Asia Pacific Cystic Fibrosis Drugs Revenue by Type (2017-2022) & (US$ Million)
Table 72. Asia Pacific Cystic Fibrosis Drugs Revenue by Type (2023-2028) & (US$ Million)
Table 73. Asia Pacific Cystic Fibrosis Drugs Sales by Application (2017-2022) & (K Pcs)
Table 74. Asia Pacific Cystic Fibrosis Drugs Sales by Application (2023-2028) & (K Pcs)
Table 75. Asia Pacific Cystic Fibrosis Drugs Revenue by Application (2017-2022) & (US$ Million)
Table 76. Asia Pacific Cystic Fibrosis Drugs Revenue by Application (2023-2028) & (US$ Million)
Table 77. Asia Pacific Cystic Fibrosis Drugs Sales by Region (2017-2022) & (K Pcs)
Table 78. Asia Pacific Cystic Fibrosis Drugs Sales by Region (2023-2028) & (K Pcs)
Table 79. Asia Pacific Cystic Fibrosis Drugs Revenue by Region (2017-2022) & (US$ Million)
Table 80. Asia Pacific Cystic Fibrosis Drugs Revenue by Region (2023-2028) & (US$ Million)
Table 81. Latin America Cystic Fibrosis Drugs Sales by Type (2017-2022) & (K Pcs)
Table 82. Latin America Cystic Fibrosis Drugs Sales by Type (2023-2028) & (K Pcs)
Table 83. Latin America Cystic Fibrosis Drugs Revenue by Type (2017-2022) & (US$ Million)
Table 84. Latin America Cystic Fibrosis Drugs Revenue by Type (2023-2028) & (US$ Million)
Table 85. Latin America Cystic Fibrosis Drugs Sales by Application (2017-2022) & (K Pcs)
Table 86. Latin America Cystic Fibrosis Drugs Sales by Application (2023-2028) & (K Pcs)
Table 87. Latin America Cystic Fibrosis Drugs Revenue by Application (2017-2022) & (US$ Million)
Table 88. Latin America Cystic Fibrosis Drugs Revenue by Application (2023-2028) & (US$ Million)
Table 89. Latin America Cystic Fibrosis Drugs Sales by Country (2017-2022) & (K Pcs)
Table 90. Latin America Cystic Fibrosis Drugs Sales by Country (2023-2028) & (K Pcs)
Table 91. Latin America Cystic Fibrosis Drugs Revenue by Country (2017-2022) & (US$ Million)
Table 92. Latin America Cystic Fibrosis Drugs Revenue by Country (2023-2028) & (US$ Million)
Table 93. Middle East and Africa Cystic Fibrosis Drugs Sales by Type (2017-2022) & (K Pcs)
Table 94. Middle East and Africa Cystic Fibrosis Drugs Sales by Type (2023-2028) & (K Pcs)
Table 95. Middle East and Africa Cystic Fibrosis Drugs Revenue by Type (2017-2022) & (US$ Million)
Table 96. Middle East and Africa Cystic Fibrosis Drugs Revenue by Type (2023-2028) & (US$ Million)
Table 97. Middle East and Africa Cystic Fibrosis Drugs Sales by Application (2017-2022) & (K Pcs)
Table 98. Middle East and Africa Cystic Fibrosis Drugs Sales by Application (2023-2028) & (K Pcs)
Table 99. Middle East and Africa Cystic Fibrosis Drugs Revenue by Application (2017-2022) & (US$ Million)
Table 100. Middle East and Africa Cystic Fibrosis Drugs Revenue by Application (2023-2028) & (US$ Million)
Table 101. Middle East and Africa Cystic Fibrosis Drugs Sales by Country (2017-2022) & (K Pcs)
Table 102. Middle East and Africa Cystic Fibrosis Drugs Sales by Country (2023-2028) & (K Pcs)
Table 103. Middle East and Africa Cystic Fibrosis Drugs Revenue by Country (2017-2022) & (US$ Million)
Table 104. Middle East and Africa Cystic Fibrosis Drugs Revenue by Country (2023-2028) & (US$ Million)
Table 105. Actavis Corporation Information
Table 106. Actavis Description and Major Businesses
Table 107. Actavis Cystic Fibrosis Drugs Sales (K Pcs), Revenue (US$ Million), Price (USD/Pcs) and Gross Margin (2017-2022)
Table 108. Actavis Cystic Fibrosis Drugs Product Model Numbers, Pictures, Descriptions and Specifications
Table 109. Actavis Recent Developments
Table 110. F. Hoffmann-La Roche Corporation Information
Table 111. F. Hoffmann-La Roche Description and Major Businesses
Table 112. F. Hoffmann-La Roche Cystic Fibrosis Drugs Sales (K Pcs), Revenue (US$ Million), Price (USD/Pcs) and Gross Margin (2017-2022)
Table 113. F. Hoffmann-La Roche Cystic Fibrosis Drugs Product Model Numbers, Pictures, Descriptions and Specifications
Table 114. F. Hoffmann-La Roche Recent Developments
Table 115. Gilead Sciences Corporation Information
Table 116. Gilead Sciences Description and Major Businesses
Table 117. Gilead Sciences Cystic Fibrosis Drugs Sales (K Pcs), Revenue (US$ Million), Price (USD/Pcs) and Gross Margin (2017-2022)
Table 118. Gilead Sciences Cystic Fibrosis Drugs Product Model Numbers, Pictures, Descriptions and Specifications
Table 119. Gilead Sciences Recent Developments
Table 120. Novartis Corporation Information
Table 121. Novartis Description and Major Businesses
Table 122. Novartis Cystic Fibrosis Drugs Sales (K Pcs), Revenue (US$ Million), Price (USD/Pcs) and Gross Margin (2017-2022)
Table 123. Novartis Cystic Fibrosis Drugs Product Model Numbers, Pictures, Descriptions and Specifications
Table 124. Novartis Recent Developments
Table 125. Vertex Pharmaceuticals Corporation Information
Table 126. Vertex Pharmaceuticals Description and Major Businesses
Table 127. Vertex Pharmaceuticals Cystic Fibrosis Drugs Sales (K Pcs), Revenue (US$ Million), Price (USD/Pcs) and Gross Margin (2017-2022)
Table 128. Vertex Pharmaceuticals Cystic Fibrosis Drugs Product Model Numbers, Pictures, Descriptions and Specifications
Table 129. Vertex Pharmaceuticals Recent Developments
Table 130. Abbott Corporation Information
Table 131. Abbott Description and Major Businesses
Table 132. Abbott Cystic Fibrosis Drugs Sales (K Pcs), Revenue (US$ Million), Price (USD/Pcs) and Gross Margin (2017-2022)
Table 133. Abbott Cystic Fibrosis Drugs Product Model Numbers, Pictures, Descriptions and Specifications
Table 134. Abbott Recent Developments
Table 135. Anthera Pharmaceuticals Corporation Information
Table 136. Anthera Pharmaceuticals Description and Major Businesses
Table 137. Anthera Pharmaceuticals Cystic Fibrosis Drugs Sales (K Pcs), Revenue (US$ Million), Price (USD/Pcs) and Gross Margin (2017-2022)
Table 138. Anthera Pharmaceuticals Cystic Fibrosis Drugs Product Model Numbers, Pictures, Descriptions and Specifications
Table 139. Anthera Pharmaceuticals Recent Developments
Table 140. Arcturus Therapeutics Corporation Information
Table 141. Arcturus Therapeutics Description and Major Businesses
Table 142. Arcturus Therapeutics Cystic Fibrosis Drugs Sales (K Pcs), Revenue (US$ Million), Price (USD/Pcs) and Gross Margin (2017-2022)
Table 143. Arcturus Therapeutics Cystic Fibrosis Drugs Product Model Numbers, Pictures, Descriptions and Specifications
Table 144. Arcturus Therapeutics Recent Developments
Table 145. Boehringer Ingelheim Corporation Information
Table 146. Boehringer Ingelheim Description and Major Businesses
Table 147. Boehringer Ingelheim Cystic Fibrosis Drugs Sales (K Pcs), Revenue (US$ Million), Price (USD/Pcs) and Gross Margin (2017-2022)
Table 148. Boehringer Ingelheim Cystic Fibrosis Drugs Product Model Numbers, Pictures, Descriptions and Specifications
Table 149. Boehringer Ingelheim Recent Developments
Table 150. Chiesi Farmaceutici Corporation Information
Table 151. Chiesi Farmaceutici Description and Major Businesses
Table 152. Chiesi Farmaceutici Cystic Fibrosis Drugs Sales (K Pcs), Revenue (US$ Million), Price (USD/Pcs) and Gross Margin (2017-2022)
Table 153. Chiesi Farmaceutici Cystic Fibrosis Drugs Product Model Numbers, Pictures, Descriptions and Specifications
Table 154. Chiesi Farmaceutici Recent Developments
Table 155. Corbus Pharmaceuticals Corporation Information
Table 156. Corbus Pharmaceuticals Description and Major Businesses
Table 157. Corbus Pharmaceuticals Cystic Fibrosis Drugs Sales (K Pcs), Revenue (US$ Million), Price (USD/Pcs) and Gross Margin (2017-2022)
Table 158. Corbus Pharmaceuticals Cystic Fibrosis Drugs Product Model Numbers, Pictures, Descriptions and Specifications
Tab

• Clinical Results in Diabetics To Be Boosted By Smart Artificial Beta Cells

For a long time, the cure for diabetes type 1 and type 2 has relied on agonizing insulin shots for patients or insulin infusion via mechanical pumps. Regarding this, experts have been creating artificial pancreatic beta cells with the he…

• High-speed Data Transmission And High Volume Needs Propel Fiber Optic Connectors Market

Fiber optic connectors are a substantial fragment of the global telecommunication industry. Optical fibers are joined using fiber optic connectors, which allow the light conduction between two consecutive optical fibers. An additional im…

• Extensive Use of Digital Technologies for Diagnostic Applications To Boost Global Optical Imaging Market

The global optical imaging system market is predicted to reach US$ 3 billion by 2024. It is expected to grow at a stable rate and will post a CAGR of more than 8% in the coming years. The growing market infiltration of digital …

• Foremost Trends In Global Pet Care Market

The global pet care market is foretold to improve in the forthcoming years as matched to the preceding years and will showcase better sales in various market segments. It is estimated that the global pet care market will grow at a CAGR o…

• China To Review Its Food Security Laws

China has arisen as the globe’s firmest developing economy. In addition, China brags about the biggest population pool in the world. In recent times, the one child policy in the republic was terminated. This is anticipated to upsur…

Global Histone Deacetylase (HDAC) Inhibitors Market Research Report 2024

Published: 10-Jan-2024        Price: US 2900 Onwards        Pages: 87

The global Histone Deacetylase (HDAC) Inhibitors market was valued at US$ 615.2 million in 2023 and is anticipated to reach US$ 1223.2 million by 2030, witnessing a CAGR of 8.8% during The forecast period 2024-2030. North American market for Histone Deacetylase (HDAC) Inhibitors is estimated to increase from $ million in 2023 to reach $ million by 2030, at a CAGR of % during The forecast period of 2024 through 2030. Asia-Pacific market for Histone Deacetylase (HDAC) Inhibitor......

Global Esomeprazole Magnesium Market Research Report 2024

Published: 10-Jan-2024        Price: US 2900 Onwards        Pages: 74

The global Esomeprazole Magnesium market was valued at US$ 5287 million in 2023 and is anticipated to reach US$ 9451.5 million by 2030, witnessing a CAGR of 8.3% during The forecast period 2024-2030. North American market for Esomeprazole Magnesium is estimated to increase from $ million in 2023 to reach $ million by 2030, at a CAGR of % during The forecast period of 2024 through 2030. Asia-Pacific market for Esomeprazole Magnesium is estimated to increase from $ million in 2......

Global Combination Therapy Drug Market Research Report 2024

Published: 10-Jan-2024        Price: US 2900 Onwards        Pages: 86

The global Combination Therapy Drug market was valued at US$ 105 million in 2023 and is anticipated to reach US$ 166.7 million by 2030, witnessing a CAGR of 4.1% during The forecast period 2024-2030. The global pharmaceutical market is 1475 billion USD in 2022, growing at a CAGR of 5% during The next six years. The pharmaceutical market includes chemical drugs and biological drugs. For biologics is expected to 381 billion USD in 2022. In comparison, The chemical drug market is......

Global Axitinib Market Research Report 2024

Published: 10-Jan-2024        Price: US 2900 Onwards        Pages: 68

The global Axitinib market was valued at US$ million in 2023 and is anticipated to reach US$ million by 2030, witnessing a CAGR of % during The forecast period 2024-2030. North American market for Axitinib is estimated to increase from $ million in 2023 to reach $ million by 2030, at a CAGR of % during The forecast period of 2024 through 2030. Asia-Pacific market for Axitinib is estimated to increase from $ million in 2023 to reach $ million by 2030, at a CAGR of % during The......

Global Lyme Disease Vaccine Market Research Report 2024

Published: 10-Jan-2024        Price: US 2900 Onwards        Pages: 70

The lyme disease vaccine can reduce lyme disease incidence, reduce symptoms and reduce mortality. Lyme disease is a tick-borne infection of spirochete, a natural disease caused by borrelia burgdorferi. The global Lyme Disease Vaccine market was valued at US$ 257 million in 2023 and is anticipated to reach US$ 763 million by 2030, witnessing a CAGR of 8.8% during The forecast period 2024-2030. The global pharmaceutical market is 1475 billion USD in 2022, growing at......

Global Transdermal Absorption Patch Market Research Report 2024

Published: 10-Jan-2024        Price: US 2900 Onwards        Pages: 85

The global Transdermal Absorption Patch market was valued at US$ million in 2023 and is anticipated to reach US$ million by 2030, witnessing a CAGR of % during The forecast period 2024-2030. North American market for Transdermal Absorption Patch is estimated to increase from $ million in 2023 to reach $ million by 2030, at a CAGR of % during The forecast period of 2024 through 2030. Asia-Pacific market for Transdermal Absorption Patch is estimated to increase from $ million i......

Global Ketoprofen Patches Market Research Report 2024

Published: 10-Jan-2024        Price: US 2900 Onwards        Pages: 78

Ketoprofen patch, indications for The treatment of symptoms caused by The following diseases: rheumatoid arthritis and rheumatoid arthritis The global Ketoprofen Patches market was valued at US$ million in 2023 and is anticipated to reach US$ million by 2030, witnessing a CAGR of % during The forecast period 2024-2030. North American market for Ketoprofen Patches is estimated to increase from $ million in 2023 to reach $ million by 2030, at a CAGR of % during The forecast per......

Global Methyl Salicylate Patches Market Research Report 2024

Published: 10-Jan-2024        Price: US 2900 Onwards        Pages: 82

The global Methyl Salicylate Patches market was valued at US$ million in 2023 and is anticipated to reach US$ million by 2030, witnessing a CAGR of % during The forecast period 2024-2030. North American market for Methyl Salicylate Patches is estimated to increase from $ million in 2023 to reach $ million by 2030, at a CAGR of % during The forecast period of 2024 through 2030. Asia-Pacific market for Methyl Salicylate Patches is estimated to increase from $ million in 2023 to......

Global Diclofenac Patches Market Research Report 2024

Published: 10-Jan-2024        Price: US 2900 Onwards        Pages: 94

The global Diclofenac Patches market was valued at US$ million in 2023 and is anticipated to reach US$ million by 2030, witnessing a CAGR of % during The forecast period 2024-2030. North American market for Diclofenac Patches is estimated to increase from $ million in 2023 to reach $ million by 2030, at a CAGR of % during The forecast period of 2024 through 2030. Asia-Pacific market for Diclofenac Patches is estimated to increase from $ million in 2023 to reach $ million by 2......

We believe in "optimum utilization of available budget and resources". While servicing our clients' (your) market research requirements, we keep the same approach in focus to help you get the best value for your $$s. Ranging from the smallest feasible / required data (datasheets, data facts, SWOT analysis, company profiles, etc) to full research reports that help you make decisions, our inventory is updated almost on a daily basis with the latest industry reports from domain experts that track more than 5000 niche sectors. Need a custom research report on medical devices market? Require all available business intelligence on 3D printing industry? Exploring F&B sector of a particular country/region? RnRMarketResearch.com is your one-stop-solution to all market intelligence needs. We not only offer custom research and consulting services, we also "bundle" reports to meet your needs and help you fetch the data analysis you require for your business. Not limited to only "finding" relevant reports for you, our client engagement team dedicates its efforts to understand your "business need" and accordingly maps available research data to help you move forward. Call "your" client engagement executive any time of your day and get your questions answered in order to make the correct business decision. Simply share your research requirement details with us and let us do all the hard work to find required intelligence for you. When you add up our "one stop solution" and "dedicated client engagement" services mentioned above, you obviously know the time and effort saving you do by working with us. Working with Fortune 500 organizations, we understand the importance of being flexible for payments. Share your payment terms with us and we will surely match up to them to ensure you get access to required business intelligence data without having to wait for the payment to be done. Have questions after reading a report / datasheet bought through us? Not sure about the methodology used for data available in the research? Talk to us / Share your questions with us and if required, we will connect you with the analyst(s)/author(s) of the report(s) and ensure you get satisfactory answers for the same. Need more data / analysis / report(s) on the topic of your research/project? The RnRMarketResearch.com team is here for you 24X7 to support you with your post-purchase requirements. Subscription Offers & Packages (Get in touch with us for more details - [email protected] / +1 888 391 5441 )

• Ad Hoc
• Pay - as - you - go / Bucket Subscriptions
• Fixed Cost for #of reports
• Customize / Personalize as per your needs